LEADER 04655nam 2200805Ia 450 001 9910965408603321 005 20251017110106.0 010 $a0-309-16583-0 010 $a1-280-17595-8 010 $a9786610175956 010 $a0-309-54451-3 035 $a(CKB)1000000000017865 035 $a(EBL)3377810 035 $a(SSID)ssj0000283921 035 $a(PQKBManifestationID)11236696 035 $a(PQKBTitleCode)TC0000283921 035 $a(PQKBWorkID)10250609 035 $a(PQKB)11399278 035 $a(MiAaPQ)EBC3377810 035 $a(Au-PeEL)EBL3377810 035 $a(CaPaEBR)ebr10072138 035 $a(CaONFJC)MIL17595 035 $a(OCoLC)923273265 035 $a(DNLM)1231404 035 $a(BIP)53860202 035 $a(BIP)11152699 035 $a(EXLCZ)991000000000017865 100 $a20041006d2005 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aScaling up treatment for the global AIDS pandemic $echallenges and opportunities /$fCommittee on Examining the Probable Consequences of Alternative Patterns of Widespread Antiretroviral Drug Use in Resource-Constrained Settings, Board on Global Health ; James Curran ... [et al.], editors 205 $a1st ed. 210 $aWashington, DC $cNational Academies Press$dc2005 215 $a1 online resource (344 p.) 300 $aDescription based upon print version of record. 311 08$aPrint version: Institute of Medicine (U.S.). Committee on Examining the Probable Consequences of Alternative Patterns of Widespread Antiretroviral Drug Use in Resource-Constrained Settings. Scaling up treatment for the global AIDS pandemic. Washington, DC : National Academies Press, ©2005 (DLC) 2004023710 311 1 $a0-309-09264-7 320 $aIncludes bibliographical references. 327 $aOpportunities and challenges -- Lessons learned -- Principles of scale-up -- Managing scale-up of antiretroviral therapy -- The path forward. 330 $aAn estimated forty million people carry the human immunodeficiency virus (HIV), and five million more become newly infected annually. In recent years, many HIV-infected patients in wealthy nations have enjoyed significantly longer, good-quality lives as a result of antiretroviral therapy (ART). However, most infected individuals live in the poorest regions of the world, where ART is virtually nonexistent. The consequent death toll in these regions-especially sub-Saharan Africa-is begetting economic and social collapse. To inform the multiple efforts underway to deploy antiretroviral drugs in resource-poor settings, the Institute of Medicine committee was asked to conduct an independent review and assessment of rapid scale-up ART programs. It was also asked to identify the components of effective implementation programs. At the heart of the committee's report lie five imperatives: Immediately introduce and scale up ART programs in resource-poor settings. Devise strategies to ensure high levels of patient adherence to complicated treatment regimens. Rapidly address human-resource shortages to avoid the failure of program implementation. Continuously monitor and evaluate the programs to form the most effective guidelines and treatment regimens for each population. Prepare to sustain ART for decades. 606 $aAIDS (Disease) 606 $aAIDS (Disease)$zDeveloping countries 606 $aAntiretroviral agents$zDeveloping countries 606 $aHighly active antiretroviral therapy 606 $aHIV Infections$xdrug therapy$3(DNLM)D015658Q000188 606 $aAntiretroviral Therapy, Highly Active$3(DNLM)D023241 606 $aDisease Outbreaks$xprevention & control$3(DNLM)D004196Q000517 606 $aHealth Planning$xorganization & administration$3(DNLM)D006285Q000458 606 $aAcquired Immunodeficiency Syndrome$3(DNLM)D000163 615 0$aAIDS (Disease) 615 0$aAIDS (Disease) 615 0$aAntiretroviral agents 615 0$aHighly active antiretroviral therapy. 615 12$aHIV Infections$xdrug therapy. 615 22$aAntiretroviral Therapy, Highly Active. 615 22$aDisease Outbreaks$xprevention & control. 615 22$aHealth Planning$xorganization & administration. 615 2$aAcquired Immunodeficiency Syndrome. 676 $a362.196/9792/0091724 701 $aCurran$b James W$01831782 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910965408603321 996 $aScaling up treatment for the global AIDS pandemic$94404663 997 $aUNINA